Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. (2020)

First Author: Horton C
Attributed to:  University of Oxford Confidence in Concept Scheme – Round 5 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/stem.3095

PubMed Identifier: 31621975

Publication URI: http://europepmc.org/abstract/MED/31621975

Type: Journal Article/Review

Volume: 38

Parent Publication: Stem cells (Dayton, Ohio)

Issue: 1

ISSN: 1066-5099